Surge In Infectious Diseases Driving The Growth Of The Market Due To Increasing Prevalence And Urbanization: Strategic Insights Driving IVD Raw Materials Market Momentum in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the IVD Raw Materials Market Size By 2025?
The market for in vitro diagnostic raw materials has experienced robust expansion recently, projected to escalate from a valuation of $25.13 billion in the year 2024 to $27.47 billion a year later, reflecting a compound annual growth rate of 9.3%. This historical upward trend is largely attributable to several key factors, notably the increasing incidence of both acute infectious conditions and long-term chronic illnesses, a surge in the requirement for tests conducted in laboratories for diagnostic purposes, greater incorporation of reagents derived from enzymes and proteins within diagnostic procedures, the widening establishment of clinical diagnostic facilities, and heightened public understanding coupled with proactive measures aimed at identifying diseases at earlier stages.

How Big Is the IVD Raw Materials Market Size Expected to Grow by 2029?
Anticipation for the in vitro diagnostic raw materials sector points toward considerable expansion in the coming years, projecting a market valuation of $39.88 billion by 2029, driven by a compound annual growth rate (CAGR) of 9.8%; this upward trajectory is fundamentally supported by escalating needs for diagnostic tools offering both speed and high levels of sensitivity, the broadening deployment of molecular diagnostic techniques in cancer treatment, an increase in the elderly demographic coupled with its associated disease prevalence, the growing requirement for complementary diagnostic agents, and augmented capital deployment from biopharmaceutical enterprises. Key shifts expected to shape this market during the forecast interval involve a movement toward raw materials synthesized or produced via recombinant methods, the necessity for distinctive materials to support the incorporation of multiplex testing capabilities, the increasing preference for reagent formulations that are lyophilized or premixed for immediate use, and innovation focused on creating specialized raw materials suitable for microfluidic platforms and lab-on-a-chip technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

Which Key Market Drivers Powering IVD Raw Materials Market Expansion and Growth?
The expanding incidence of contagious illnesses is anticipated to serve as a catalyst for the expansion of the IVD raw materials sector moving ahead. These communicable ailments stem from pathogenic microbes capable of transmission between individuals or other life forms; this rising prevalence is linked directly to swift urbanization, as heightened population concentration strains both waste management systems and medical support structures, thereby facilitating disease spread. Because IVD raw materials are foundational to creating precise diagnostic tools necessary for the early identification and proficient handling of these diseases, they are vitally important in the fight against infectious outbreaks. To illustrate this trend, data from the Statens Serum Institut, a Danish medical testing facility, revealed a rise in chronic hepatitis C diagnoses between 2021 and 2022: 146 cases were recorded in 2021, with males accounting for the majority at 72 percent (105); this figure climbed to 196 cases in 2022, where males still represented the larger segment at 67 percent (131). Consequently, the mounting rate of infectious diseases is directly fueling the progression of the IVD raw materials market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the IVD Raw Materials Market?
Leading enterprises within the in vitro diagnostic raw materials sector are concentrating their efforts on engineering sophisticated offerings, notably establishing IVD production sites, with the objective of bolstering localized diagnostic proficiency and fostering greater healthcare autonomy. These specialized IVD production centers serve as hubs for the conception, fabrication, and rigorous quality assurance testing of instruments and apparatus employed in laboratory analyses of bodily samples external to the human physique for disease identification. Illustratively, in the month of January 2024, an alliance was forged between Colexa Biosensor Limited, a technology firm hailing from Nigeria, and Codix Pharma Limited, a Nigerian pharmaceutical producer, resulting in the inauguration of the inaugural in vitro diagnostics manufacturing plant for Sub-Saharan Africa, situated in Lagos. This establishment, responsible for fabricating the onpoint blood glucose meter and its accompanying strips, represents a pivotal advancement for the continent's medical sector, specifically tailored to counter the escalating incidence of diabetes and enhance the availability of testing. Initial capacity for this location stands at an output of 3.6 million units per year, with provisions in place to scale production up to 10.8 million units, prioritizing the fulfillment of requisites across West Africa.

What Are the Emerging Segments in the IVD Raw Materials Market?
The ivd raw materialsmarket covered in this report is segmented -

1) By Product: Antibodies; Antigens; Enzymes; Proteins; Biological Buffers; Other Products
2) By Technology: Molecular Diagnostics; Clinical Chemistry; Immunochemistry; Other Technologies
3) By End User: Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations; Other End Users

Subsegments:
1) By Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Antibodies
2) By Antigens: Recombinant Antigens; Native Antigens; Synthetic Antigens
3) By Enzymes: Polymerases; Reverse Transcriptases; Oxidases
4) By Proteins: Carrier Proteins; Blocking Proteins; Recombinant Proteins
5) By Biological Buffers: Tris Buffers; HEPES Buffers; Phosphate Buffers
6) By Other Products: Stabilizers; Surfactants; Preservatives

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24270&type=smp

Who Are the Global Leaders in the IVD Raw Materials Market?
Major companies operating in the IVD raw materials market are F. Hoffmann-La Roche, Merck KGaA, Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Becton dic*kinson and Company (BD), Agilent Technologies, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc.

Which are the Top Profitable Regional Markets for the IVD Raw Materials Industry?
North America was the largest region in the IVD raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the IVD raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24270

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.